skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: Nome da Publicação: Journal of Viral Hepatitis remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity

Bachmetov, L. ; Gal-Tanamy, M. ; Shapira, A. ; Vorobeychik, M. ; Giterman-Galam, T. ; Sathiyamoorthy, P. ; Golan-Goldhirsh, A. ; Benhar, I. ; Tur-Kaspa, R. ; Zemel, R.

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.e81-e88 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
2
Early post‐liver transplant use of direct‐acting antivirals in naive and NS5A inhibitor‐experienced HCV patients
Early post‐liver transplant use of direct‐acting antivirals in naive and NS5A inhibitor‐experienced HCV patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early post‐liver transplant use of direct‐acting antivirals in naive and NS5A inhibitor‐experienced HCV patients

Saracco, Margherita ; Tandoi, Francesco ; Maletta, Francesca ; Balagna, Roberto ; Romagnoli, Renato ; Martini, Silvia

Journal of viral hepatitis, 2023-03, Vol.30 (3), p.201-208 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study

Rodriguez-Torres, M. ; Glass, S. ; Hill, J. ; Freilich, B. ; Hassman, D. ; Di Bisceglie, A. M. ; Taylor, J. G. ; Kirby, B. J. ; Dvory-Sobol, H. ; Yang, J. C. ; An, D. ; Stamm, L. M. ; Brainard, D. M. ; Kim, S. ; Krefetz, D. ; Smith, W. ; Marbury, T. ; Lawitz, E.

Journal of viral hepatitis, 2016-08, Vol.23 (8), p.614-622 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Antiviral resistance and specifically targeted therapy for HCV (STAT-C)
Antiviral resistance and specifically targeted therapy for HCV (STAT-C)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antiviral resistance and specifically targeted therapy for HCV (STAT-C)

Thompson, A. J. V. ; McHutchison, J. G.

Journal of viral hepatitis, 2009-06, Vol.16 (6), p.377-387 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus
Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus

Morikawa, K. ; Lange, C. M. ; Gouttenoire, J. ; Meylan, E. ; Brass, V. ; Penin, F. ; Moradpour, D.

Journal of viral hepatitis, 2011-05, Vol.18 (5), p.305-315 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy
The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy

Bartenschlager, R.

Journal of viral hepatitis, 1999-05, Vol.6 (3), p.165-181 [Periódico revisado por pares]

Oxford, UK: Blackwell Science Ltd

Texto completo disponível

Citações Citado por
7
NS3 protease polymorphisms and genetic barrier to drug resistance of distinct hepatitis C virus genotypes from worldwide treatment-naïve subjects
NS3 protease polymorphisms and genetic barrier to drug resistance of distinct hepatitis C virus genotypes from worldwide treatment-naïve subjects
Material Type:
Artigo 		Adicionar ao Meu Espaço

NS3 protease polymorphisms and genetic barrier to drug resistance of distinct hepatitis C virus genotypes from worldwide treatment-naïve subjects

Vidal, L. L. ; Soares, M. A. ; Santos, A. F.

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.840-849 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?
Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?

Holmes, J. A. ; Desmond, P. V. ; Thompson, A. J.

Journal of viral hepatitis, 2012-10, Vol.19 (10), p.677-684 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis
Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis

Anzola, M.

Journal of viral hepatitis, 2004-09, Vol.11 (5), p.383-393 [Periódico revisado por pares]

Oxford, UK: Blackwell Science Ltd

Texto completo disponível

Citações Citado por
10
New developments in HCV therapy
New developments in HCV therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

New developments in HCV therapy

Kronenberger, B. ; Zeuzem, S.

Journal of viral hepatitis, 2012-01, Vol.19 (s1), p.48-51 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.